Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Canadian Pfizer partner sues to head off patent lawsuit over COVID-19 vaccine

by AIP Online Bureau | Mar 18, 2022 | Health, International News, Pandemic

The lawsuit is part of a growing web of patent disputes over COVID-19 vaccine technology. Arbutus sued Moderna over its mRNA technology last month, but has not yet sued Pfizer or Acuitas Pfizer and Moderna were hit with patent lawsuits on Thursday by Alnylam...

Pfizer Covid pill nearly 90% effective, works on Omicron, shows lab data

by AIP Online Bureau | Dec 14, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Pandemic, Policy, Workplace/Employee Benefits

77 countries have now reported cases of Omicron & the reality is that Omicron is probably in most countries, even if it hasn’t been detected yet. Omicron is spreading at a rate we have not seen with any previous variant, said Tedros Ghebreyesus,...
Covid: Pfizer, BioNTech say third dose neutralises Omicron variant

Covid: Pfizer, BioNTech say third dose neutralises Omicron variant

by AIP Online Bureau | Dec 8, 2021 | Eco/Invest/Demography, Health, International News, Pandemic

Pfizer Chief Executive Officer Albert Bourla “It’s clear from these preliminary data that protection is improved with a third dose,” Pfizer Chief Executive Officer Albert Bourla said in a statement. The initial data show a third dose could offer still offer enough...

Covid boosters cleared for all US adults as FDA widens access

by AIP Online Bureau | Nov 19, 2021 | Facts, Health, Pandemic

“We have absolutely no chance in the current situation to control the pandemic without providing boosters to everyone,” BioNTech CEO Ugur Sahin told reporters during a visit to Washington last week. “ US regulators on Friday opened up COVID-19 booster shots to all...

Pfizer to allow generic versions of its COVID pill in 95 countries

by AIP Online Bureau | Nov 16, 2021 | Health, International News, Non-Life, Pandemic, Policy

Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, has said the pill cut the chance of hospitalisation or death for adults at risk of severe disease by 89% in its clinical trial. read more The drug will be used in combination with ritonavir, an...
Next Entries »

Recent Posts

  • Insurance firm not liable to pay compensation for death of persons driving rashly: SC
  • Axis Max Life Insurance reports cyber threat at unit
  • (no title)
  • (no title)
  • IRDAI drops plans to tweak existing bancassurance rules for curbing mis-selling by insurers

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy